Vol. 4 No. 3 (2017): Volume 4 Issue 3 2017

Articles

• Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience

  Alessandra Fusco, Sara Colarusso, Marco Piscopo, Marco Piscopo, Maria Rosaria Improta, Marco Corigliano, Emilia Martedi, Emilia Martedi, Domenica Oliva, Domenica Oliva, Antonietta Santorelli, Antonietta Santorelli, Rosa Simonetti, Rosa Simonetti, Armando Giammarco, Caterina Colella, Caterina Colella, Luigia Miretto, Luigia Miretto, Alessandra D’Alessandro, Viviana Russo, Viviana Russo, Giuseppina Guarino, Giuseppina Guarino, Giampiero Marino, Giampiero Marino, Gerardo Corigliano, Felice Strollo, Sandro Gentile (Author)

  46-56

  • pdf

• Cardioprotective Effect of Losartan Alone or in Combination with Remote Ischemic Preconditioning on the Biochemical Changes Induced by Ischemic/Reperfusion Injury in a Mutual Prospective Study with a Clinical and Experimental Animal Arm

  Ehab S. EL Desoky, Ayman K. M. Hassan, Safaa Y. Salem, Sabah A. Fadil, Amira F. Taha (Author)

  57-65

  • pdf

• Three-Dimensional Printing in Cardiovascular Disease: Verification of Diagnostic Accuracy of 3D Printed Models

  Zhonghua Sun, PhD, FSCCT* (Author)

  66-70

  • pdf

• Where are Cell-Based Therapies Heading? Current Limitations and Future Directions

  Gen Suzuki, Rebeccah F. Young, Harue Suzuki (Author)

  71-77

  • pdf

• Chest Pain Without Coronary Artery Obstruction and Calcification in Young Women May Indicate Left Ventricular Diastolic Dysfunction

  Riri Watanabe, Masao Moro, Mitsuaki Isobe (Author)

  78-86

  • pdf